AI assistant
TANFAC Industries Ltd. — Major Shareholding Notification 2020
Apr 14, 2020
61879_rns_2020-04-14_4b92191c-d3cb-4937-a4a4-1cdde81b369a.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
ANSHUL SPECIALTY MOLECULES PRIVATE LIMITED
CIN: U24100MH1971PTC015364
Registered Office: Flexcel Park, C Wing, 2[nd] Floor, S. V. ROAD, Near 24 Karat Multiplex, Jogeshwari (West), Mumbai 400102. Phone No. 022 62252900 / Email: [email protected]
No. ASMPL/2020-21/- 14[th] April, 2020
BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai - 400 001.
Email : ‘[email protected]’
Sub: Disclosure under Regulation 29(2) of SEBI (Substantial Acquisitions of Shares & Takeovers) Regulations, 2011.
Dear Sirs,
Please find enclosed Disclosure under Regulation 29(2) of SEBI (Substantial Acquisitions of Shares & Takeovers) Regulations, 2011, for your information and record.
Kindly take the disclosure on record and acknowledge the receipt.
Thanking you,
Yours faithfully,
For ANSHUL SPECIALTY MOLECULES PVT. LTD.
Sd/-
MR. RAVI A. SHROFF
DIRECTOR
BSE - INTERNAL
ANSHUL SPECIALTY MOLECULES PRIVATE LIMITED
CIN: U24100MH1971PTC015364
Registered Office: Flexcel Park, C Wing, 2[nd] Floor, S. V. ROAD, Near 24 Karat Multiplex, Jogeshwari (West), Mumbai 400102.
Phone No. 022 62252900 / Email: [email protected]
Format for disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
| 1. | Name of the Target Company (TC) | TANFAC INDUSTRIES LIMITED | TANFAC INDUSTRIES LIMITED | TANFAC INDUSTRIES LIMITED |
|---|---|---|---|---|
| 2. | Name(s) of the acquirer and Persons Acting in Concert (PAC) with the acquirer |
ANSHUL SPECIALTY MOLECULES PVT. LTD. (Acquirer) KAMALJYOT INVESTMENTS LTD.(PAC) |
||
| 3. | Whether the acquirer belongs to Promoter/Promotergroup |
NO | ||
| 4. | Name(s) of the Stock Exchange(s) where the shares of TC areListed. |
BSE Limited | ||
| 5. | Details of the acquisition / disposal as follows |
Number | % w.r.t. total share/voting capital wherever applicable (*) |
% w.r.t. total diluted share/voting capital of the TC (**) |
| Before the acquisition / disposal under consideration, holding of: a) Shares carrying voting rights b) Shares in the nature of encumbrance (pledge/lien/non-disposal undertaking / others) c)Voting rights (VR) otherwise than by shares d)Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) |
15,62,926 -- -- -- |
15.67 -- -- -- |
15.67 -- -- -- |
|
| Total (a+b+c+d) | 15,62,926 | 15.67 | 15.67 | |
| Details of acquisition/sale a)Shares carrying voting rights acquired /sold b)VRs acquired /sold otherwise than by shares c)Warrants / convertible securities / any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired / sold d) Shares encumbered / invoked / released by the acquirer |
4,000 -- -- -- |
0.04 -- -- -- |
0.04 -- -- -- |
|
| Total(a+b+c+/-d) | 4,000 | 0.04 | 0.04 | |
BSE - INTERNAL
ANSHUL SPECIALTY MOLECULES PRIVATE LIMITED CIN: U24100MH1971PTC015364
Registered Office: Flexcel Park, C Wing, 2[nd] Floor, S. V. ROAD, Near 24 Karat Multiplex, Jogeshwari (West), Mumbai 400102. Phone No. 022 62252900 / Email: [email protected]
| After the acquisition/ sale, holding of: a) Shares carrying voting rights b) Shares encumbered with the acquirer c) VRs otherwise than by shares d) Warrants / convertible securities / any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition |
15,66,926 -- -- -- |
15.71 -- -- -- |
15.71 -- -- -- |
|
| Total (a+b+c+d) | 15,66,926 | 15.71 | 15.71 | |
| 6. | Mode of acquisition/sale (e.g. open market / off-market / public issue/ right issue / preferential allotment / inter-se transferetc). |
OPEN MARKET | ||
| 7. | Date of acquisition/sale of shares /VR or date of receipt of intimation of allotment of shares, whichever is applicable |
13-04-2020 | ||
| 8. | Equity share capital /total voting capital of the TC before the said acquisition/ sale |
99,75,000 Shares | ||
| 9. | Equity share capital /total voting capital of the TC after the said acquisition/ sale |
99,75,000 Shares | ||
| 10. | Total diluted share/voting capital of theTC afterthe said acquisition/ sale. |
99,75,000 Shares |
(*) Total share capital/voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement.
(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
For Anshul Specialty Molecules Pvt. Ltd.
Place: Mumbai
Sd/-
Date: 14-04-2020 Ravi A. Shroff - Director
DIN: 00033505
BSE - INTERNAL